These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 38564341)

  • 1. Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance.
    Collins JA; Osheroff N
    ACS Infect Dis; 2024 Apr; 10(4):1097-1115. PubMed ID: 38564341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Zoliflodacin and
    Collins JA; Basarab GS; Chibale K; Osheroff N
    ACS Infect Dis; 2024 Aug; 10(8):3071-3082. PubMed ID: 39082980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Series of Spiropyrimidinetriones that Enhances DNA Cleavage Mediated by
    Byl JAW; Mueller R; Bax B; Basarab GS; Chibale K; Osheroff N
    ACS Infect Dis; 2023 Mar; 9(3):706-715. PubMed ID: 36802491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-Mediated Fluoroquinolone Resistance in
    Collins JA; Oviatt AA; Chan PF; Osheroff N
    ACS Infect Dis; 2024 Apr; 10(4):1351-1360. PubMed ID: 38606464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV.
    Gibson EG; Oviatt AA; Cacho M; Neuman KC; Chan PF; Osheroff N
    Biochemistry; 2019 Nov; 58(44):4447-4455. PubMed ID: 31617352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
    Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
    J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with
    Morgan H; Lipka-Lloyd M; Warren AJ; Hughes N; Holmes J; Burton NP; Mahenthiralingam E; Bax BD
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
    Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
    J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Action of Mycobacterium tuberculosis Gyrase Inhibitors: A Novel Class of Gyrase Poisons.
    Gibson EG; Blower TR; Cacho M; Bax B; Berger JM; Osheroff N
    ACS Infect Dis; 2018 Aug; 4(8):1211-1222. PubMed ID: 29746087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between Gepotidacin and
    Oviatt AA; Gibson EG; Huang J; Mattern K; Neuman KC; Chan PF; Osheroff N
    ACS Infect Dis; 2024 Apr; 10(4):1137-1151. PubMed ID: 38606465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DNA Gyrase to Combat Mycobacterium tuberculosis: An Update.
    Das S; Garg T; Srinivas N; Dasgupta A; Chopra S
    Curr Top Med Chem; 2019; 19(8):579-593. PubMed ID: 30834837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones.
    Basarab GS; Ghorpade S; Gibhard L; Mueller R; Njoroge M; Peton N; Govender P; Massoudi LM; Robertson GT; Lenaerts AJ; Boshoff HI; Joerss D; Parish T; Durand-Reville TF; Perros M; Singh V; Chibale K
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0219221. PubMed ID: 35266826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase.
    Gibson EG; Bax B; Chan PF; Osheroff N
    ACS Infect Dis; 2019 Apr; 5(4):570-581. PubMed ID: 30757898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents.
    Tari LW; Li X; Trzoss M; Bensen DC; Chen Z; Lam T; Zhang J; Lee SJ; Hough G; Phillipson D; Akers-Rodriguez S; Cunningham ML; Kwan BP; Nelson KJ; Castellano A; Locke JB; Brown-Driver V; Murphy TM; Ong VS; Pillar CM; Shinabarger DL; Nix J; Lightstone FC; Wong SE; Nguyen TB; Shaw KJ; Finn J
    PLoS One; 2013; 8(12):e84409. PubMed ID: 24386374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
    Yague G; Morris JE; Pan XS; Gould KA; Fisher LM
    Antimicrob Agents Chemother; 2002 Feb; 46(2):413-9. PubMed ID: 11796351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of a Novel Bacterial Topoisomerase Inhibitor against
    Dauda SE; Collins JA; Byl JAW; Lu Y; Yalowich JC; Mitton-Fry MJ; Osheroff N
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Water-Metal Ion Bridge in Quinolone Interactions with
    Carter HE; Wildman B; Schwanz HA; Kerns RJ; Aldred KJ
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
    Urushibara N; Suzaki K; Kawaguchiya M; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
    Microb Drug Resist; 2018; 24(1):1-7. PubMed ID: 28504916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.
    Chan PF; Germe T; Bax BD; Huang J; Thalji RK; Bacqué E; Checchia A; Chen D; Cui H; Ding X; Ingraham K; McCloskey L; Raha K; Srikannathasan V; Maxwell A; Stavenger RA
    Proc Natl Acad Sci U S A; 2017 May; 114(22):E4492-E4500. PubMed ID: 28507124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Landscape of Phenotypic and Transcriptional Responses to Ciprofloxacin in Acinetobacter baumannii: Acquired Resistance Alleles Modulate Drug-Induced SOS Response and Prophage Replication.
    Geisinger E; Vargas-Cuebas G; Mortman NJ; Syal S; Dai Y; Wainwright EL; Lazinski D; Wood S; Zhu Z; Anthony J; van Opijnen T; Isberg RR
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.